PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1817465

Meconium for drug testing.

E C Maynard·L P Amoruso·W Oh
View original source ↗Export metadata ↓

Abstract

Samples of meconium from 28 neonates born to women suspected of drug abuse were tested for drugs of abuse (ie, cocaine, morphine, codeine, and marijuana). In each case, testing of urine from the mother, the newborn, or both had been ordered by the attending physician because of suspected maternal drug abuse. Seventeen (61%) of 28 meconium samples tested positive; 28 (60%) of 47 urine samples were positive. Meconium test results were concordant with the results of maternal or newborn urine testing in 24 (86%) of the 28 cases. In three cases, meconium was positive for cocaine when newborn urine was negative; in one case, meconium was negative when maternal urine was positive for cocaine. Compared with the combination of maternal and newborn urine testing, meconium testing had an 82% positive predictive value (14/17) and a 91% negative predictive value (10/11). Collection of meconium is simpler and more reliable than collection of urine, and testing of meconium was easily incorporated into routine procedures at a busy commercial laboratory. Meconium is a useful sample for drug detection in newborns.

Explore related subjects

CocaineFemaleHumansIllicit DrugsInfant, NewbornMeconiumPredictive Value of TestsPregnancyPregnancy ComplicationsSubstance-Related DisordersJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E C Maynard, L P Amoruso, W Oh. 1991. Meconium for drug testing.. https://doi.org/10.1001/archpedi.1991.02160060068022

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Delusional parasitosis and the dopamine transporter. A new insight of etiology?

Delusional parasitosis (DP) is a psychotic condition in which a person has the unshakeable and mistaken belief (delusion) and/or aberrant perception (hallucination) of being infested with parasites. The disorder will be usually classified in a primary DP-group without a detectable cause (so-called pure forms), while secondary DP-groups are associated with general organic conditions, psychiatric illnesses and drugs (substance induced). Etiology and pathophysiology of DP remain however unknown. In the present paper we hypothesize for the first time a decreased striatal dopamine transporter (DAT)-functioning (corresponding with an increased extracellular dopamine-level) as etiologic condition for DP (primary and secondary groups). The DAT as key regulator of the dopamine-reuptake in the human brain is well known (regulation of the extracellular dopamine concentration). It is a presynaptic plasma membrane protein highly dense represented in the striatum. The hypothesis of a decreased DAT-functioning as etiologic condition by DP is revealed in case reports which show that DAT-inhibitors, such as cocaine, pemoline, methylphenidate and other amphetamine-derivatives can induce the clinical expression of DP. Several other associated causes of secondary DP-groups (medications, parkinson, chorea huntington, multiple system atrophy, diabetes, cerebrovascular diseases, alcoholism, traumatic brain injury, hyperuricemia, human immunodeficiency virus, iron deficiency, schizophrenia, depression) suggest that the clinical expression of DP may be related to a decreased striatal DAT-functioning (blocking, reduced ligand binding, reduced density, reduced activity). Our examined DP-cases (2-females) show means of magnetic resonance imaging a structurally damaged striatum. Furthermore, we presume that by the primary DP-group, the physiologically age-related decline of the DAT-density is pathologically elevated. Based on this hypothesis we show in the present paper the relation between DP and decreased striatal DAT-functioning, trying to give a new insight into the pathophysiologically mechanism involved. The hypothesis provides supporting evidence that increased levels of extracellular dopamine in the striatum of DP-patients is likely to be the result of decreased DAT-functioning and not increased rates of release. The hypothesis can be investigated simply by dopamine transporter imaging in patients with DP.

Cocaine↗
PubMed2006

Design and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2beta-carbomethoxy-3beta-biphenyltropane.

Tropane-based photoaffinity ligands covalently bind to discrete points of attachment on the dopamine transporter (DAT). To further explore structure-activity relations, a ligand in which the photoactivated group was extended from the 3-position of the tropane ring was synthesized from cocaine via a Stille or Suzuki coupling strategy. 3-(4'-Azido-3'-iodo-biphenyl-4-yl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester (11; K(i) = 15.1 +/- 2.2 nM) demonstrated high binding affinity for the DAT. Moreover, this compound showed moderate binding affinity for the serotonin transporter (SERT, K(i) = 109 +/- 14 nM), suggesting the potential utility of [(125)I]11 in both DAT and SERT protein structure studies.

Cocaine↗
PubMed2006

Interpreting the color effect of melanin on cocaine and benzoylecgonine assays for hair analysis: brown and black samples compared.

This paper examines the hypothesis that cocaine and BE assays of hair demonstrate a putative bias effect for darker color hair samples. Although such an effect has been reported in the literature, no one has examined this claim outside the bounds of simple significance of mean difference. In this paper a large number of black and brown hair samples are compared for cocaine and BE concentration values, and this comparison is evaluated for both significance and effect size. Two innovative measures are used to assess this relationship - a calculation of effect size using Cohen's d, and the use of an ROC curve to evaluate the potential for a dark color bias. The paper reports mixed results for significance, but consistent results for effect size. There does not appear to be any significant effect for cocaine. While BE demonstrates a significant mean difference, both the effect size and the ROC analysis show the effect to be trivial.

Cocaine↗